Participating Factulty: Real-World Impact of Infliximab Precision-Guided Dosing on Management of Patients With IBD

Faculty

Bincy P. Abraham, MD, MS

Professor of Clinical Medicine

Department of Medicine

Houston Methodist Academic Institute

Houston, TX

Patricia Aragon Han, MD, MAS

Clinical Research Scientist

Prometheus Laboratories Inc

San Diego, CA

Robert Battat, MD, CM

Assistant Professor of Medicine (position during program)

Division of Gastroenterology and Hepatology

NewYork-Presbyterian Hospital/Weill Cornell Medical College

New York, NY

Director (current position)

Center for Clinical Excellence and Translational Research in Inflammatory Bowel Diseases

Centre hospitalier de l’Université de Montréal

Montreal, Quebec

Canada

Thierry Dervieux, PharmD, PhD

Chief Scientific Officer

Prometheus Laboratories Inc

San Diego, CA

Andrew Shim, PharmD, JD

Vice President of Medical Affairs

Prometheus Laboratories, Inc

San Diego, CA

David A. Ziring, MD

Associate Director

Division of Pediatric Gastroenterology

Cedars-Sinai Medical Center

Los Angeles, CA

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Bincy P. Abraham, MD, MS

OTHER

EMPOWER Program

Patricia Aragon Han, MD, MAS

EMPLOYMENT

Prometheus Laboratories Inc

Robert Battat, MD, CM

CONSULTANCIES OR PAID ADVISORY BOARDS

AbbVie; Bristol Myers Squibb; Eli Lilly; Janssen; Pfizer; Prometheus Laboratories Inc; Takeda Pharmaceutical Company

OTHER

EMPOWER Program

Thierry Dervieux, PharmD, PhD

EMPLOYMENT

Prometheus Laboratories Inc

Andrew Shim, PharmD, JD

EMPLOYMENT

Prometheus Laboratories Inc

STOCK OWNERSHIP

Prometheus Laboratories Inc

David A. Ziring, MD

LECTURE FEES

Prometheus Laboratories Inc

OTHER

EMPOWER Program

INSTITUTIONAL CONFLICTS OF INTEREST

Cedars-Sinai Medical Center